In The Cancer Genome Atlas (TCGA) cohort, TMIGD2 was more prominently expressed in FAB M0-M2 subtypes, acute promyelocytic leukemia (FAB M3), and FAB-M6 acute erythroid leukemia (Supplementary Fig. 1d)20. This evidence concerns the gene TMIGD2 and acute erythroid leukemia.